---
figid: PMC11089157__fonc-14-1376496-g005
figtitle: Emerging roles of FOXK2 in cancers and metabolic disorders
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11089157
filename: PMC11089157__fonc-14-1376496-g005.jpg
figlink: /pmc/articles/PMC11089157/figure/F5
number: F5
caption: FOXK2 facilitates recruitment of various co-inhibitory or co-activating complexes
  for transcriptional regulation of its downstream target gene FOXK2 recruits NuRD,
  SIN3A, NCoR/SMRT, and REST/CoREST to cooperatively impede the expression of HIFβ
  and EZH2. Additionally, it collaborates with SIN3A/HDAC to synergistically inhibit
  the expression of ATGs. Furthermore, FOXK2 recruits ASXL/BAP1 to collaboratively
  suppress the expression of VHL, SOC1/2, TXINP, and other genes participating in
  cellular metabolism and proliferation. In contrast, FOXK2 recruits AP-1 to activate
  the expression of AP-1-dependent target genes. Moreover, it recruits phosphorylated
  DVL to induce the expression of Wnt-related genes, ultimately activating the Wnt
  signaling pathway
papertitle: Emerging roles of FOXK2 in cancers and metabolic disorders
reftext: Xiaoke Xing, et al. Front Oncol. 2024;14(NA).
year: '2024'
doi: 10.3389/fonc.2024.1376496
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: FOXK2 | cancer | chemotherapy resistance | post-translational modifications
  | de novo nucleotide synthesis | metabolic disorders
automl_pathway: 0.8721989
figid_alias: PMC11089157__F5
figtype: Figure
redirect_from: /figures/PMC11089157__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11089157__fonc-14-1376496-g005.html
  '@type': Dataset
  description: FOXK2 facilitates recruitment of various co-inhibitory or co-activating
    complexes for transcriptional regulation of its downstream target gene FOXK2 recruits
    NuRD, SIN3A, NCoR/SMRT, and REST/CoREST to cooperatively impede the expression
    of HIFβ and EZH2. Additionally, it collaborates with SIN3A/HDAC to synergistically
    inhibit the expression of ATGs. Furthermore, FOXK2 recruits ASXL/BAP1 to collaboratively
    suppress the expression of VHL, SOC1/2, TXINP, and other genes participating in
    cellular metabolism and proliferation. In contrast, FOXK2 recruits AP-1 to activate
    the expression of AP-1-dependent target genes. Moreover, it recruits phosphorylated
    DVL to induce the expression of Wnt-related genes, ultimately activating the Wnt
    signaling pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NCOR2
  - NCOR1
  - HIF1A
  - EPAS1
  - HIF3A
  - ARNT
  - ARNT2
  - BMAL1
  - FOXK2
  - EZH2
  - REST
  - SIN3A
  - RCOR1
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - BAP1
  - RNF2
  - MAGI1
  - VHL
  - SHOC2
  - TXNIP
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
---
